AAAAAA
Results: 26-40/40
Atypical chronic myelogenous leukemia following immunosuppressive therapy for severe aplastic anemia
Authors:
Robak, T
Kasznicki, M
Strzelecka, B
Bartkowiak, J
Debiec-Rychter, M
Citation: T. Robak et al., Atypical chronic myelogenous leukemia following immunosuppressive therapy for severe aplastic anemia, LEUK LYMPH, 35(1-2), 1999, pp. 193
Authors:
Robak, T
Blasinska-Morawiec, M
Blonski, JZ
Dmoszynska, A
Citation: T. Robak et al., 2-chlorodeoxyadenosine (cladribine) in the treatment of elderly patients with B-cell chronic lymphocytic leukemia, LEUK LYMPH, 34(1-2), 1999, pp. 151-157
Authors:
Robak, T
Gora-Tybor, J
Urbanska-Rys, H
Krykowski, E
Citation: T. Robak et al., Combination regimen of 2-chlorodeoxyadenosine (cladribine), mitoxantrone and dexamethasone (CMD) in the treatment of refractory and recurrent low grade non-Hodgkin's lymphoma, LEUK LYMPH, 32(3-4), 1999, pp. 359-363
Authors:
Robak, T
Wierzbowska, A
Blasinska-Morawiec, M
Korycka, A
Blonski, JZ
Citation: T. Robak et al., Serum levels of IL-6 type cytokines and soluble IL-6 receptors in active B-cell chronic lymphocytic leukemia and in cladribine induced remission, MEDIAT INFL, 8(6), 1999, pp. 277-286
Authors:
Robak, E
Blonski, JZ
Bartkowiak, J
Niewiadomska, H
Sysa-Jedrzejowska, A
Robak, T
Citation: E. Robak et al., Circulating TCR gamma delta cells in the patients with systemic lupus erythematosus, MEDIAT INFL, 8(6), 1999, pp. 305-312
Authors:
Hellmann, A
Lewandowski, K
Zaucha, JM
Bieniaszewska, M
Halaburda, K
Robak, T
Citation: A. Hellmann et al., Effect of a 2-hour infusion of 2-chlorodeoxyadenosine in the treatment of refractory or previously untreated Waldenstrom's macroglobulinemia, EUR J HAEMA, 63(1), 1999, pp. 35-41
Authors:
Robak, T
Blasinska-Morawiec, M
Blonski, J
Hellmann, A
Halaburda, K
Konopka, L
Kotlarek-Haus, S
Potoczek, S
Hansz, J
Dmoszynska, A
Urasinski, I
Zdziarska, B
Dwilewicz-Trojaczek, J
Holowiecki, J
Skotnicki, AB
Citation: T. Robak et al., 2-chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia and hairy cell leukemia variant: 7-year experience in Poland, EUR J HAEMA, 62(1), 1999, pp. 49-56
Authors:
Robak, T
Blonski, JZ
Urbanska-Rys, H
Blasinska-Morawiec, M
Skotnicki, AB
Citation: T. Robak et al., 2-chlorodeoxyadenosine (cladribine) in the treatment of patients with chronic lymphocytic leukemia 55 years old and younger, LEUKEMIA, 13(4), 1999, pp. 518-523
Authors:
Maranda, E
Szmigielska, A
Robak, T
Citation: E. Maranda et al., Additive action of gemcitabine (2 ',2 '-difluorodeoxycytidine) and 2-chlorodeoxyadenosine on murine leukemias L1210 and P388, CANCER INV, 17(2), 1999, pp. 95-101
Authors:
Chrusciel, J
Blonski, J
Szymczyk, P
Robak, T
Kilianska, ZM
Citation: J. Chrusciel et al., A novel B-CLL specific nuclear protein (p44/46), LEUK RES, 23(9), 1999, pp. 833-841
Authors:
Smolewski, P
Niewiadomska, H
Krykowskii, E
Robak, T
Citation: P. Smolewski et al., Expression of p21 and MDM-2 proteins on tumor cells in responding and non-responding patients with Hodgkin's disease, NEOPLASMA, 46(4), 1999, pp. 212-218
Authors:
Wierzbowska, A
Urbanska-Rys, H
Robak, T
Citation: A. Wierzbowska et al., Circulating IL-6-type cytokines and sIL-6R in patients with multiple myeloma, BR J HAEM, 105(2), 1999, pp. 412-419
Authors:
Robak, E
Wozniacka, A
Sysa-Jedrzejowska, A
Biernat, W
Robak, T
Citation: E. Robak et al., Disseminated superficial actinic porokeratosis in a patient with systemic lupus erythematosus, BR J DERM, 141(4), 1999, pp. 759-761
Authors:
Robak, T
Gladalska, A
Stepien, H
Robak, E
Citation: T. Robak et al., Serum levels of interleukin-6 type cytokines and soluble interleukin-6 receptor in patients with rheumatoid arthritis, MEDIAT INFL, 7(5), 1998, pp. 347-353
Authors:
Maranda, E
Juszczynski, P
Robak, T
Citation: E. Maranda et al., Amifostine inhibits antineoplastic activity of 2-chlorodeoxyadenosine in mice with L1210 and P388 leukemia, CANC J, 11(6), 1998, pp. 309-314